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Background:   Medication errors are a national  concern, and even small  changes can 
make  a  real  difference  in  reducing  harm to  patients.  Dose  omissions  are  one  of  the 
medication errors causing harm, and it  is  a recommendation for  NHS organisations to 
periodically audit all omissions to help target where improvements can be performed to 
prevent these errors.
Aim and objectives: The aim of the project was to collect numbers of frequency, reasons 
and the relative risk of causing harm to patients for dose omissions in surgical settings at 
The Ayr Hospital. From the results the aim was also to create guidelines to help inform 
ward staff about medicines that should not be omitted in the peri-operative period.
Methods:  A prospective  study was  performed in a  hospital  electronic  prescribing  and 
medicine administration (HEPMA) system to study dose omission patterns for a period of 
three  weeks  at  two  surgical  wards.  Clinical  information  was  collected  from  patients 
suffering from dose omissions that were included in the study by giving their consent. An 
expert group of 4 pharmacists evaluated the omitted doses after a new assessment for 
scoring clinical significance, and guidelines were developed from the findings.  
Results: The total numbers of dose omissions in both settings were10.1% and 6.0%,  and 
there were several differences between the two settings. Of all omitted doses evaluated for 
clinical significance 41.2% were scored as possible to cause a disturbance to the patient's 
symptom control in some degree.  
Discussion: The different outcomes at the two wards can possibly be explained by the 
frequency of surgeries performed in each ward, turnover of patients and use of different 
medicine supply systems. Scoring of clinical significance of omissions would possibly vary 
by the selection of patients because there are many important individual aspects.    
Conclusion: Dose  omissions  are  common and  many of  them are  possible  to  cause 
disturbance to patients symptom control when omitted in the peri-operative period.
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Abbreviations
95% CI 95 % Confidence Interval
CNS Central Nervous System
COPD Chronic Obstructive Pulmonary Disease
EPMA Electronic Prescribing and Medicine Administration
HEPMA Hospital Electronic Prescribing and Medicine Administration
MRSA Methicillin- Resistant Staphylococcus Aureus
NBM Nil By Mouth
NHS National Health Service
NSAID Non Steroidal Anti Inflammatory Drug
OSD One Stop Dispensing
POD Patient’s Own Drugs
POE Prescription Order Entry
PRN Pro Re Nata (as required)
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1.1 Medicine incidents causing harm 
Although most medicines are prescribed and used safely,  sometimes things go wrong. 
Most medicines are self administrated by the patient at home, and there are few numbers 
and reports of incidents caused by errors in this setting. But studies have shown that up to 
6.5 per cent of admissions to hospital are related to harm from medicine.1
From evidence suggesting, it is calculated that up to ten per cent of all  patients within 
hospitals in Scotland experience medication-related harm.2 Of the reported incidents witch 
caused harm in  hospitals  in  the UK in  2007 over  30% were caused by patient  being 
allergic to the treatment. Omitted medicine/ingredient caused 22%, wrong route 19% and 
wrong medicine 17%. There is a gap between the actual number of incidents that occur 
and the number that is reported.1  About 50% of all incidents causing harm are avoidable, 
and  it  is  obvious  that  preventing  this  in  any  way  possible  is  both  significance  and 
important.2
1.1.1 Categorisation of medicine incidents
The  National  Patient  Safety  Agency  has  defined  a  patient  safety  incident  as  “any 
unintended or unexpected incident which could have or did lead to harm for one or more 
patients”. A medication error is one kind of incident, where there has been an error in on of 
the processes listed below:1 
 Prescribing (ordering a given medicine or dose)
 Dispensing (supplying medicines to hospital wards)
 Preparation (preparing a dose of medicine for administration)
 Administration  (administering  the  dose  of  medicine  by  the  appropriate  route, 
method and time)
 Monitoring (checking the administration and effect of a medicine)
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The  most  frequent  recorded  medication  incidents  is  administration  errors.1 An 
administration error is any difference between what the patients received or was suppose 
to receive, and what the person in charge of prescribing medicines intended in the original 
order3. The errors that can happen are1:
 Dose given at the wrong time 
 Wrong dose; quantity, strength, route or  formulation
 Wrong frequency
 Other  medicine  is  given  instead  of  the  prescribed  medicine  (similar  names, 
packages etc.)
 Medicine given to the wrong patient
 Medicine used passed expiry date
 Dose omitted 
 Incorrect administration, wrong technique (injections over too short time e.g.) 
 Wrong dose preparation
 Unauthorised
 Inappropriate  combinations  of  medicine  and  food,  (calcium  combined  with 
tetracycline or inappropriate admixtures with parenteral therapy e.g.). 
1.2 Dose omissions as a medicine incident
Of all reported medication incidents occurring in hospitals in the UK in 2007, 17.1% were 
omitted  medicine,  which  involved  both  entirely  missing  a  medicine  from  an  intended 
medicine regimen, and missing one or more doses of a medicine.1 A dose omission is 
defined as when the patient fails to receive a ordered dose of medication before the next 
dose is due or it is evident that the dose will not be given before that time. Wrong dose 
was the only one that had a higher frequency, 28.7%, while 11.5% was caused by wrong 
medicine1.
1.2.1 Identification of reasons for dose omissions
Incidents of omitted doses may occur when a hospital medicines supply system fails or 
when  hospital  pharmacy  opening/closing  times  lead  to  delay  in  medicine  being 
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administered to the patient.  Certain medicines need to be prescribed in response to the 
newest  laboratory  result  to  the  patient.  If  the  result  is  delayed  or  not  available  the 
prescription may not  be written by the time the dose is  due.1  Other  reasons for  dose 
omissions are listed in table 1. 
Table 1 Different reasons for dose omissions in general
Event Reason
Unavailable medicine Medicine not available in the hospital needs to be 
ordered.
Nil-by-mouth The person in charge of prescribing the patients 
medicines have decided to take the patient off some 
medicines in the nil-by mouth period
Theatre The patient are having surgery
Unable to swallow The patient have trouble taking oral medicine, an 
alternative route should be used 
Patient absent from ward The patient is not at the ward at the time for 
medication, and needs to get it as soon as he or she 
returns
Refused The patient refuses to take the medicine
Withheld The person in charge of prescribing the patients 
medicines have decided that the medicine should not 
be given or monitoring of the patients condition, blood 
pressure, blood glucose levels or other lab results 
make the dose clinical inappropriate to give
IV-access unavailable The patients IV access is not usable
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1.2.2 Earlier studies of amount and reasons for omitted doses
A prospective study was performed at The Ayr Hospital between in 1997- 1998 4,5 over the 
reasons for dose omissions in the orthopaedic, surgical ward, witch is also one of the 
clinical settings in this study. The collection of omitted doses was collected both before and 
after electronic prescribing and administration (EPMA) was introduced to the Hospital. This 
system will be presented in more detail later. The findings from the study are presented in 
table 2.
Table 2 Frequency of reasons for omitted doses compared to the total number of 
prescribed doses, at the orthopaedic surgical ward in Ayr  Hospital  performed in 
1997- 1998  
Omission Before EPMA (n= 3364) 1 month after EPMA (n= 3334)
n % n %
Kardex unavailable eg 
theatre, X ray 7  0.2 -
Nurse decision 35 1.0 32 1.0
Drug unavailable 19 0.6 19 0.6
Fasting patient 20 0.6 28 0.8
Unclear prescription 6 0.2 -
No cause 17 0.5 1 0.03
Total 104 3.1 80 2.4
  
Some of the main findings from other studies from the UK are represented below. They are 
all performed after 2006.
In  the  Pharmacy Department  at  Kings  College  Hospital  foundation  trust  in  London  a 
retrospective study was done. Number of given and omitted doses of the patients regular 
medicine within 24 hours was collected from 22 wards. In total 6888 doses was supposed 
to be given to 404 patients. Of this 473 doses was omitted, which gives a percent of 6.9%. 
48.3% of the omitted doses were medicine withheld while 14.6% was caused by NIL by 
mouth and 9.7% from unavailable medicine (6.1% outside pharmacy opening time, and 
3.6% during). In 8.9% of the cases the medicine was unable to give by prescribed route, 
and 7.0% were refused by the patient. Omissions were caused by 3.8% as a result of the 
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patient being absent from ward. In the remaining 7.7% the reason was unknown.6
Another study in London was performed in Queen Elizabeth Hospital  NHS trust on all 
medical wards. The study went on for one week, including weekend. In total 714 omitted 
doses were recorded, of an unknown number of doses in total.  Of them 37.7% of the 
doses were not given because the patient refused and 15.7% were caused by NIL by 
mouth. In 15.3% the drugs were unavailable and 11.5% were withheld. There were also a 
few cases where the reasons for dose omission were patient off ward, or because the 
drugs were  non formulary drugs (both 1.3%).  There were also 11.3% unknown cases 
because the nurse had not documented why the dose had been omitted, and 5.9% were 
noted as other.7
 
A third study was performed in three different hospitals in London, Highgate Mental Health 
Centre, St. Pancras Hospital and St. Lukes Hospital. The information of omitted doses was 
obtained from the patient’s drug charts in a five-day period. In total 37% of all doses that 
were suppose to be given were omitted. About 60% of them were caused by patient not 
available, 24% by patient refusing, 13% by unavailable medicine and 11% by medicine not 
charted, (which gives a total of 108%).8
At the City Hospitals Sunderland NHS Foundation Trust the result from a one week- period 
audit on elderly wards was that 10% of the doses were omitted. There are no notifications 
of the reasons for the omissions.9
1.3 Clinical significance of dose omissions
Short time medication omissions are in most cases unlikely to cause harm to patients and 
not widely recognised as a risk. But of all incidents resulting in harm reported in hospitals 
in the UK in 2007, about 22% was caused by omitted medicines or doses. Of the cases 
leading  to  severe  harm  and  death,  omitted  medicine  caused  18.5%  and  7.9% 
respectively.1 
It is an important point of view that missed doses can have no clinical significance in some 
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situations, while in others it may result in therapeutic failure, relapse and withdrawal.9  
The outcome will in most cases depend on the patient’s clinical condition, medical history, 
sex, age and the reason for why that medicine is being used. What situation the medicine 
is omitted in will also be of great significance, like if the patient is going through surgery or 
if there is a worsening in the patient’s condition. A general rule is that the more critical the 
situation is the more critical is also a dose omission of a medicine used to treat or prevent 
the sickness behind it. 
Table 3. The National Patient Safety Agency definition of harm to the patient
Categories of harm to the patient Defined outcomes
No harm Any patient safety incident that ran to completion but 
no harm occurred to the person(s)
Low harm Any  patient  safety  incident  that  required  extra 
observation  or  minor  treatment,  and caused minimal 
harm to the person(s) 
Moderate harm Any patient safety incident that resulted in a moderate 
increase in treatment, and which caused significant but 
not permanent harm to the person(s) 
Severe harm Any patient safety incident that resulted in permanent 
harm to the person(s) 
Death Any patient safety incident that directly resulted in the 
death of the person(s) 
1.3.1 High risk medicines
Research  studies  have  showed  that  single  omitted  doses  of  medicines  such  as  anti-
convulsants, insulin and anticoagulants can have serious and even fatal consequences. 
Also  medicines  used  to  treat  epilepsy  or  prevent  strokes  has  been  reported  to  have 
caused permanent harm or death when omitted1.
There  has  also  been  reported  cases  of  patients  on  long  term  treatment  with  steroid 
supplement who experienced to be profoundly hypotensive and hypoxic after omission of 
16
the medicine for 24 hours.1
Several  other  medicines  are  known  to  be  important  medicines  which  should  not  be 
omitted. What to do when a medicine is omitted is usually described in the medicines 
instructions in the package. Mostly it is recommended to take the dose as fast as possible, 
unless if too long time has passed. A general rule is less than half the normal dosage 
interval, but this depends on the agent. To double the next dose instead can for some 
medicines  cause  toxic  levels,  like  lithium  and  caumadin.  Sometimes  the  patients  are 
advised to make contact with his or hers doctor if important medicine is omitted.  
1.3.2 Scoring clinical significance of dose omissions
 
There is a need for classification of clinical significance of all types of drug omissions, to 
avoid incidents from happening which can cause harm to the patient. 
The scoring of clinical outcomes from medicine incidents have in earlier, validated studies 
been scaled in systems from 0 to 10. 0 represented a case with no potential  effect of 
causing harm to the patient and 10 a case that would result in death. Scoring omitted 
doses, especially single doses will rarely top this scoring system.3,10
To achieve reliable scores scaling clinical significance at least four judges are required, 
and the mean score should be used as a severity factor. Earlier studies suggest that the 
professionals that score each case can be any experienced UK pharmacists, medical staff 
and nursing staff.  Their  mean scores would be generalizable to any other four judges 
selected from the same group.10
1.3.3 Earlier studies and observations of dose omissions and clinical significance.
There are not many studies performed of the clinical significance of dose omissions in the 
UK. Two are discussed here, and as a supplement a study made in the US is presented. 
In the study performed at Ayr Hospital in 1997- 19984, the method described above (scale 
of clinical significance from 0 to 10) was used in the study. Of 184 omitted doses there 
were 67.4% of the doses that scored higher than 0. None of the omitted doses scored 
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higher than 4.  
Table 4 Scored clinical significance of omitted doses from the orthopaedic, surgical 
ward at Ayr Hospital






In the study performed in Queen Elizabeth Hospital NHS 182 of 714 doses (25.5%) were 
categorized as high risk medication.7 Of them isosorbide mononitrate and benzylpenicillin 
were mentioned to have a reduced efficacy to the patients controlling anginal pain and 
infections respectively if omitted. Medicine considered to be low risk medicine in this study 
included mainly senna, lactulose, paracetamol and co-codamol. But an important aspect in 
this study was that no indication for  the medications use and other information of  the 
patient was collected.7
In  a  study  performed in  the  US in  200211,  clinical  significance  were  scored  from the 
medication errors observed in 36 health care facilities by a expert panel of physicians. 
Medical history and other clinical information were collected about each patient. In total 
19% of the doses observed had some kind of error and 30% of them were dose omission. 
In total 288 dose omissions were judged by the experts, and 17 cases (6%) were clinical 
significant.  This  expression  clinical  significant  was set  to  be  “the  potential  to  cause a 
patient discomfort or jeopardize the patient’s health and safety”. Some of the medicines 
mentioned to be scored like this were warfarin and phytonadione.
1.4 Medication in the peri-operative period 
Medications used before, during and after surgery (the peri-operative period) are different 
in many ways from medication given on medical wards. Some drugs needs to be stopped 
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days or even weeks before surgery in order to reduce the risks they may impose upon the 
procedure. Other medicines must be continued as normal, and on top of that there are 
medicines  witch  needs  to  be  given  as  supplementary  treatment  in  the  peri-operative 
period.12 If it is not an emergency surgery, a meeting with the patient will be arranged some 
time before to agree on the medical regime before the admission to the hospital. Some 
important points of view that need to be considered are given in this section.
1.4.1 Discontinuation of medicine 
Before surgery the international normalized ratio should be under 1.5, because of the risk 
of bleeding during procedure. Warfarin is usually discontinued three to four days before 
surgery to accomplish this.13 Aspirin can also increase bleeding and is withdrawn 7-9 days 
before  certain  types  of  surgery  to  allow  sufficient  replacement  of  normal  circulating 
platelets.  In  some cases aspirin  is  chosen to  be  continued,  like  when  the  patients  is 
suffering from unstable angina or those undergoing cardiac surgery. Other NSAIDs should 
also be stopped for the same reasons, and the withdraw period varies after how long-
acting the NSAID is.14Drugs that also increase the risk of venous thromboembolism (VTE) 
such  as  combined  oral  contraceptives  should  be  stopped  4  weeks  before  major 
operations,15 and raloxifene should be stopped three days before surgery.12 
The kidney perfusion gets reduced in the peri-operative period and the person in charge 
for  prescribing  medicines  needs to  be  aware  of  medicines  that  gets  metabolized and 
eliminated through this system. Combined with tissue damage during surgery,  reduced 
kidney  function  can  lead  to  hyperkalemia.  Therefore  potassium-sparing  diuretics  are 
usually omitted on the morning of surgery,  or a non potassium-sparing diuretic can be 
used.13 
Medicines that  interact with peri-operative drugs, like monoamine-oxidase needs to be 
discontinued two weeks before surgery or an anesthetic that does not interact can be 
used. In worst scenario an interaction like that can lead to coma and death. It  is also 
important  to  remember  that  discontinuing  some  medicines  may  affect  the  efficacy  or 
toxicity of others.13,14,16
Patients suffering from diabetes are considered to be at an increased risk of peri-operative 
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complications, like acute metabolic problems, infections and delayed wound healing, and 
mortality.  It  is  important  to  maintain  optimal  blood  glucose  levels  and  avoid  these 
complications. Stress, as a response to surgery, raises the blood glucose levels. Withhold 
of food, insulin and other diabetic medicines should be minimized and it is recommended 
that  surgery  in  these  patients  should  be  held  in  the  morning  to  reduce  the  fasting 
period.17,18
There are also some other medicines that should be stopped prior to surgery and there are 
guidelines that the nurses and doctors should follow.12
1.4.2 Continuation of medicine
There is clear evidence for continuation for some drugs, like medicines used to control life-
threatening conditions. It is also essential to optimize the treatment of patient with chronic 
diseases so that they are in the best condition to cope with and recover from surgery. An 
example  is  antiepileptics  that  are  usually  continued  because  abrupt  withdrawal  may 
precipitate rebound seizures.
Patients  suffering  from  cardiovascular  disease  have  an  increased  risk  of  myocardial 
infarction, and it is important that these patients get their medication as prescribed and that 
no doses are omitted.13  A very important medicine is the beta-blocker.  When a patient 
normally uses these medicines the beta-adrenoceptor system is upgraded. If  the beta-
blocker is omitted, this system will be unmasked, and the patients will be more sensitive to 
the sympathetic effect of stress hormones. This will especially be a problem in the peri-
operative period when these hormones are secreted in large amounts. The withdrawal 
effects can be seen already after 12 to 72 hours after stopping betablockade.13 
Other medicines that should be continued throughout the peri-operative period:14
 Antiparkinson drugs
 Antipsychotics and anxiolytics
 Corticosteroids
 Drugs for asthma
 Drugs for dependence
 Immunosuppressant
20
 Selective serotonin re-uptake inhibitors
Continuation may require that the drug is administered by an alternative route or change to 
a similar product.14
1.4.3 Medicines supplements
Even if  surgery increases the  risk  of  bleeding,  it  also  increases the  risk  of  VTE with 
triggering the coagulation cascade19,  which make the right treatment with anticoagulant 
therapy very important in the peri-operative period. The evaluation is done on an individual 
level, where other risk factors like age, obesity, varicose veins, thrombophilias, immobility 
and previous history of VTE plays an important role.15,20
People  using  corticosteroids  regularly  (>  or  =  5mg),  like  patients  suffering  from 
Rheumatoid  Arthritis  or  Chronic  Obstructive  Pulmonary Disease (COPD),  need steroid 
supplement because stress connected to surgery can make the body require a higher 
dose of steroids. (25-100mg * 4).  A too low level of steroids can cause hypo adrenal crisis, 
manifesting  as  circulatory  collapse  and  shock.16 These  medicines  also  needs  to  be 
restarted as soon as the patient can swallow small amounts of water again, or through an 
alternative route. 
Medicines preventing nausea, vomiting, pain and surgical site infections (SSI) are also 
upgraded compared to the patient’s normal regimen. Nausea and vomiting are a common 
problem in the peri-operative period. Opioid analgesia,  anesthetics, fear and injury are 
some of the reasons for patients experience these reactions. It is easier to prevent it from 
happen,  than to  treat  it  when it  has already started.  Even a  single  dose reduces the 
incidence by about 30 per cent21,  and omitted doses of these types of  medicines can 
cause a lot of discomfort to the patient. That makes this medicine an important dose to 
give a patient going through surgery, even if it is rarely fatal.21
When it  comes to  treatment  of  pain,  omitted doses in a  medicine-regimen can cause 
inadequately controlled pain, which cause morbidity and major discomfort to the patient.22
Surgical site infections (SSI) are a complication that is often seen because of bacterial 
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contamination  during  surgery.  One  of  the  things  that  are  used  to  deal  with  this  is 
antibacterial  prophylaxis.  If  there  is  a  high  risk  of  post-operative  infections,  antibiotics 
should be used prophylactic. The patient should receive a single dose within two hours 
before surgery and another dose three hours after surgery to keep the infection rate down. 
For patients using longtime antibiotics, surgical prophylaxis may not be necessary, but the 
timing of dosing is still important to get the best effect of the antibiotics.23
1.4.4 Pre-operative period
Patients  are  in  risk  of  aspirating  their  stomach  contents  during  general  anesthesia. 
Because of this there should be a fasting period, Nil by mouth (NBM), for six hours for food 
before anesthetics are given. Clear water leave the stomach within two hours of ingestion, 
an that makes it possible to give routine medication to the patient during this time.14,19,24 
A proton pump inhibitor or a H2- antagonist could also reduce the risks of gut problems.16
There are other reasons for a patient to be labeled NBM, like unconsciousness, to rest the 
gut or post-operatively as a result of the surgery itself.19  
The result of not giving a dose can have different outcomes from one patient to another, 
and in many cases it will depend on the patient’s health condition. So if a drug should be 
given or not in the nil by mouth period is for the doctor to decide.19
Hypotension can also occur at any time around surgery, because of blood and fluid loss 
and the use of cardiovascular medicines (anti hypertensives, anti-arrhythmic and drugs for 
angina). Extra fluid replacement may be necessary in these cases.14,19
1.4.5 Postoperative period
Most medicines that have been stopped prior to surgery should be restarted at the original 
dose as soon as the patient is able to take oral medication. But circumstances may exist 
where the patient needs the medicine in a different form than before.25 Reasons for this 
can be nausea, vomiting or delayed gastric emptying caused by the drugs they have been 
given. If the operation was in the gut, head or neck or if the patient needs intubation or 
ventilation, there could also be a need for alternative routes for medications.14 
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Changes to the patients’ medicine regime should be planned before surgery if possible. 
Advices  should  be  sought  from  the  hospital  pharmacist  or  medical  team  where 
appropriate.14  This is  important  because the dose and frequency that  is  prescribed by 
mouth may not be the same for another route.19 
Some medicines should not be restarted until the risks associated with surgery has been 
totally removed, such as the risk of VTE and use of contraceptives.14
1.4.6 Present pre-operative fasting and drug administration guidelines at the sur-
gical wards at Ayr Hospital
The following guidelines are the current practice at all surgical wards at the Ayr Hospital.26 
It applies to all patients who are being prepared for a surgical procedure unless specific 
written  instructions  have  been  documented  by  the  anaesthetist.  This  instructions  are 
written at the anaesthetic record for each patient, and it includes fasting procedures that 
can differ  from the  general  guidelines and what  medicines  that  should be  withheld  or 
continued.
Fasting Guidelines:
 6 hours –  Solid food, milk or drinks containing milk
 2 hours – water
Elective morning lists:
Fasted for solids from midnight
Fasted for fluids from 7 am
Elective afternoon list:
Early breakfast prior to 7 am, then fast for solids.
Fasted for fluids from 11 am.




 oral anti-diabetic agents 
 warfarin  
 clopidogrel. 
1.5 Medicines  management  and  Improvements  to  reduce  medication 
incidents in the UK  
The primary and secondary healthcare in the UK are controlled by the health service NHS, 
which was created in 1948, and divided into NHS (England), NHS Wales, NHS Scotland 
and the Health  and Social  care in  Northern Ireland.  The four  health  services produce 
guidelines and reports which are all used in the UK. 
There has been a great focus on how patients should receive better  and equally high 
quality of care in the UK for some time now. In 2000 the NHS published “The NHS Plan: a 
plan  for  investments,  a  plan  for  reform”,  which  was  a  plan  for  how the  governments 
increase  in  investment  to  the  health  services  should  be  distributed.27  NHS  Scotland 
published “Our national health – a plan for action, a plan for change” around the same 
time. The focus was put on the health service situation and changes that needed to be 
made to improve the NHS itself and the nation's health.28
1.5.1 Hospital medicines management systems
Medicines management is a system of processes and behaviours that determines how 
medicines are used by patients and by the NHS. It should make the use of medicines cost 
effective,  safe  and  effective.  It  encompasses  the  entire  way  medicines  are  selected, 
procured, delivered, prescribed, administered and reviewed. 
There are many studies showing that hospitals do not always manage their medicines to 
the best effect. But with effective medicine management systems, better targeted care will 
be delivered, and improved compliance will be seen caused by better information to the 
patients.29 
In  2001 the Audit  Commission published the  report  “A spoonful  of  sugar  –  Medicines 
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Management in NHS Hospitals.”29 This report  was written as a remedy to identify how 
good medicines are managed in hospitals. It presents suggestions for how challenges and 
issues can be met and overcome and how the systems can be improved to be more 
effective. 
The fourth report from the Patient Safety Observation, Safety in doses: Medication Safety 
Incidents  in  the  NHS from 2004  represents  seven  key actions  to  improve medication 
safety, especially in hospitals. One of them is to ensure medicines are not omitted. By 
identification of the scope of the problem and the reasons for the omissions, the problems 
can be found and action taken. It highlights the importance in looking at the whole process, 
from medicine storage and supply systems to  administration itself. Increased reporting 
system,  routines for  documentation,  good communication and an improvement  in  staff 
skills through training and information is also a step in the right direction.1  
1.5.2 Medicines storage and supply
When patients are admitted to hospital, their current drug regime needs to be manifested 
and new drugs prescribed, and there can be many medicines that are not available at the 
ward. Each ward has a medicines room with stock items, normally medicines which are 
commonly used, and the most important medicines a patient may need. What medicines 
that are chosen as stock items depend on what kind of ward it is. A medicine ward will 
need different medicine stocked than a surgery ward.  
The hospital pharmacies normally supply medicines to the wards, and during their opening 
times all medicines can be ordered, as long as the pharmacy stocks them. Communication 
between wards and hospital pharmacies is important in ensuring the appropriate, safe and 
timely supply  of  medicines.  Ordering  of  medicines  is  sometimes  done  by nurses and 
sometimes by trained technicians in charge for the top up of the medicines room. 
When the pharmacy is closed in the evenings and in the weekends, an emergency room 
with different amounts of medicines will be available at every hospital. In some cases the 
staff also decides to borrow medicines from other wards. If the medicine is not available at 
the hospital, it will have to be ordered from other instances. A review of medicines storage 
and medication supply chains should be done regularly, to prevent unavailable medicines.1 
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1.5.3 Administration of medicines 
The nurses at the wards are both in charge of administration of regular and “if necessary” 
medicine, and are trusted to be able to give the right medicines to the right patients. During 
administration of medicines, there is as mentioned many factors that can lead to errors, 
and it is important that standard procedures are known by all staff and followed in daily 
practice, so there is no room for mistakes. The Nursing & Midwifery Council published the 
“National  Standards  for  Medicine  Management”  in  2007,  as  a  replacement  for  The 
Guidelines for Administration of Medicine from 2004. This is a guide to enable nurses and 
midwives to think through issues and be more able to judge situations in the best interests 
for their patients.30 
Abridgement from Standard 8: 30
 You  must  make  a  clear,  accurate  and  immediate  record  of  all  medicine 
administered, intentionally withheld or refused by the patient, ensuring the signature 
is clear and legible (...)
 Where medicine is not given the reason for not doing so must be recorded
The  standards  do  not  give  any more  detailed  prescriptions  of  what  to  do  in  different 
settings where medicines are being omitted.
1.5.4 Communication and routines for documentation
Good communication between staff members is essential to minimise medication errors 
like omitted medicine. It is also important for ensuring that the patient receives the right 
care, and that the patient’s recovery and discharge is not delayed. This also requires good 
routines  for  documentation.  But  for  every time the  prescription  or  other  information  is 
rewritten, it’s a new chance for medicine errors to occur. Some of the weaknesses within 
hospitals that can lead to errors:  
 incomplete or incorrect medication history on admission to hospital
 Illegible or incomplete prescriptions 
 The use of abbreviations leading to misunderstandings. 
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 Some charts are kept at another place than the main chart. This could be medicines 
that needs different monitoring, or that should be given in unusual times. 
 incorrect or incomplete discharge medicines
 poor information about medicine on discharge from hospital
 lack of monitoring or follow-up on discharge
1.5.5 Training and information – improvement in staff skills 
It is obvious that new clinicians need good training and information when they first start 
working. But there is a need for continuing training and competency assessments for all 
clinicians who are involved in the prescription and administration of medicines, even if they 
have worked as clinicians for many years. This can help to keep the safety in medicine 
management up and prevent accidents.259
1.5.6 Pharmaceutical care 
Pharmaceutical  care  is  a  very  important  part  of  Medicine  management.  “The  right 
Medicine – a strategy for pharmaceutical care in Scotland”, a strategy for pharmaceutical 
care in Scotland, was published in 2001 as a respond to the NHS Plan published the year 
before. It summarises pharmaceutical care as a systematic, patient-centred approach. The 
pharmacist should identify, resolve and prevent medicine-related problems. The result is 
that the right medicine will be given in the right dose and at the right time. In the end each 
patient will get the desired treatment for each medical condition. 31 The pharmacist should 
also make sure that understandable information is given to the patient, like advice in use of 
their  medicine,  common side  effects  and  what  the  patient  should  do  if  a  medicine  is 
forgotten.2 
In a pharmacist work to manage this goals, a regularly review of the medicine charts in 
hospitals  is  performed.  When  recording  medication  histories,  medicine  omissions  can 
easily be identified, corrected and put more focus on.  Studies by the Audit Commission 
and Healthcare Commission show that more hospital pharmacists are now spending time 
on wards doing activities such as this.1 
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1.5.7 Re-designing the service
In both “The NHS Plan” and “Our National Health” which are mentioned above, there is a 
focus on new services to improve Hospital Medicine Management Systems. This includes 
topics like 
 new ways of supplying medicine from the pharmacy to the wards 
 patients using their own medicine brought with them on admission to hospital
 self administration of medicine
Many improvements  of  medicines  management  have  been  performed at  Ayr  Hospital 
included The Safer Patient Initiative that also is a wide project in the UK. The aims with this 
project  were  to  reduce  mortality  by  15%,  adverse  events  by  30%  and  harm  from 
anticoagulation by 50%. 
Targets for improvements were set to be better information to patients, new protocols and 
easily accessible electronic laboratory results. A greater focus was also put on the process 
reconciliation, used to find out what medicines the patients already use when they are 
admitted to hospital or transferred between wards. Supply systems of medicine from the 
pharmacy to  the  wards  have  also  been  redesigned  at  The  Ayr  Hospital,  and  will  be 
described in detail below, as an important understanding for this project.32
1.6 Electronic prescribing and administration of medicines
The plan from NHS Scotland from 2000 presented how a lot more money would be put 
into communication technology to make the information flow faster both within the hospital 
and between the hospital and the community.28  From 2003-2006 the NHS prioritised ₤6.2 
billions on the IT programme “Connecting for health”.33 
1.6.1 Benefits and drawbacks of electronic prescribing and administration
The  scope  of  introducing  the  system  was  to  replace  the  existing  prescribing  and 
administration  charts  with  a  paperless,  electronic  system.  This  was  because repeated 
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audits demonstrated that improvements were required.5 The most important benefits of the 
system was thought to be legible prescriptions, a reduction in the number of prescribing 
and administration dispensing errors and information available at the point of the need. 
The drawbacks of the system were the price of the hardware and provision of support and 
training when there is a high turnover of junior medical staff.34
Studies comparing electronic prescribing to the old method show a decline in medication 
related errors, like reduction in prescribing errors and pharmacists interventions.35 They 
also show an improvement of legibility and completeness of prescriptions.36  But there are 
also new types of risks with electronic prescribing. These mainly involve selection of the 
incorrect  product,  dose or frequency from a list,  and inappropriate  use or  selection of 
default doses.35,36,37 Even if there are few quantitative data about the benefits from a UK 
perspective at present,36 there are plans about making it a national system.38  
1.6.2 Electronic prescribing and administration at Ayr Hospital
Ayr  hospital  is  the  only  hospital  in  Scotland  using  electronic  prescribing,  and  it  was 
introduced to the hospital as a pilot in 1997. The system is called Prescription Order Entry 
(POE),  and  is  a  part  of  the  hospital  electronic  filing  system.  In  combination  with  the 
hospitals electronic medicine administration system, it is called EPMA. 
In the study described earlier from Ayr Hospital5 one of the main objects was to compare 
prescribing  and  administration  errors  before  and  after  implementation  of  the  EPMA 
system.  Numbers  of  errors  was  collected  from  both  one  and  12  months  after 
implementation, and compared with numbers from when the paper-system was still in use. 
The study showed that both prescribing and administration errors got significantly better 
after  the  implementation,  especially  after  12  months  of  use.  The  frequency  of 
administration errors fell from 9.0 to 5.4 (p<0.001) and more medicines were administrated 
on time. (IV drugs and controlled drugs were not included among these errors.) At the 
same time the study showed a different pattern of event type, like an increase of incorrect 
dose given. But in total the system was concluded to be at least as safe as the existing 
manual system.5 
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EPMA is now in use on all  wards at  Ayr  Hospital,  and this means easy access to all 
information  kept  at  the  computers  at  any  time  and  place  within  the  hospital  for  the 
clinicians  involved  in  the  patient  medicine  team.  This  includes  information  such  as 
medicine  history,  lab  results,  X-rays,  pharmaceutical  care  plan  and  documentation  of 
administration  of  each medicine dose.  The reasons for  omissions can be watched by 
accessing each medicine prescribed, and both time for prescribed dosing time and the 
actual time when the medicine was given can be observed. If a dose is omitted the reason 
have to be filled out before the next dose can be documented, and because of that there 
are no room for unknown omissions which could be seen in the paper based system. 
1.7 Different supply systems at Ayr Hospital
There are three different supply systems at Ayr Hospital: The Traditional Top up, Medicine 
Redesign System and a new pilot that they are trying out. There are several differences 
between them when it comes to involvement from technicians, patients using their own 
medicines,  storing  of  medicines  at  the  wards  and  how  new  prescriptions  are  being 
handled.39,40  The different systems are running in different wards at the moment. Which 
systems that will be used in each ward are still to be decided in the nearest future. 
1.7.1 The Traditional top up 
This is the old system, which also could be found in many other hospitals in Scotland. The 
wards have a medicine room with basic drugs (on stock drugs) which is topped up by a 
technician normally one or two times a week. Before they go to the ward they would write 
out a list from HEPMA off all the drugs the patients are on, and then they would check that 
these things are at the ward. Things that the patient need which are not stock-drugs would 
be put in a separate trolley. The technician would also tidy up the medicine room and the 
trolley, take out overstock items and check the expiry date of the drugs. 
Besides this, the staff nurses order all new drugs and items they are short of several times 
a day from the pharmacy. These drugs will be sent down again with a porter or with the 
pipe-delivery system. 
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Patients are also asked to bring some own medicines from home such as insulin, different 
hormones or other non-formula items witch the pharmacy do not stock.
1.7.2 Medicine redesign system
There are two wards in the hospital  that are using this system, a surgical ward and a 
medical ward. The system has been running for 5 and 2 years respectively. 
One part of the redesign system is one-stop dispensing (OSD), which is dispensing only 
once for the patient during a single hospital  admission. Label with full  instructions and 
patient information leaflet are, where possible, dispensed in original pack(s). 
Patients at this stations use their own medicine which they bring along from home. They 
also use this on discharge, or get a new supply for at least 14 days. The medicines are 
checked up against the patient medicine prescription chart before it  can be used. The 
drugs conditions are also checked by a technician (or a nurse) first, and if they are in bad 
condition  or  the  use-by  dates  has  expired  the  patient  receives  new  ones  from  the 
pharmacy. With this method they get an idea of the patient’s compliance, and what he or 
she knows about their own medicines. This method is a bit time consuming because it 
takes time to go through the patients own drugs, but about the same time is saved when it 
comes to discharge because the patient's medicines are ready a lot faster. It also reduces 
the wastage of medicines.
The patient's drugs, an amount for at least 14 days, are kept in a bedside locker, except 
for drugs that they might need (PRN medicine). There is a small amount of stock items 
such as antibiotics, lactulose, nebulas and painkillers. This is because a lot of patients are 
using  them,  and  they  try  to  avoid  opening  too  many  packages  at  the  same  time. 
Medication in the lockers can only be administered to the patient on the label.
There is a technician up at the wards every day, except for the weekends. They write out 
lists from HEPMA over all new medicines prescribed and a list over all new patients, which 
they go through to make sure they have all the medicines they need available. They also 
check patients who have been there for 14 days, and top up their bedside lockers. Insulin, 
eye drops and intravenous liquids that have expiry dates less than this are checked more 
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often. The technician keeps a diary of things that have to be checked up on what date. 
They also top up the ward twice a week, as they do at traditional top up. 
The  nurse  can  also  order  things  that  might  have  been  forgotten  or  things  that  they 
suddenly needs after the technicians have left the ward for the day. It will then be sent up 
by the pipe-system, or with a porter.
1.7.3 Pilot of a new supply system
This system is a pilot that started running on the 15th September 2008 and so far it only 
exists in one ward. Three times a day (8:00AM, 12:45PM and 15:00PM) the technicians 
write out a document of all new drugs that have been prescribed that is not a stock drug 
and a list of new patients on the ward since the last time. Then they put a label on the 
medicines with the patients name on and send them to the wards through a tube delivery 
system that runs within the walls or with the porter. Because it is still a pilot, there are no 
instructions on the medicines. The nurses then put the medicines in the patient’s bedside 
lockers. 
Once a week (Tuesdays) a technician goes to the ward and tides up the on-stock items, 
which are drugs the patients might need and other drugs witch normally are used on the 
ward. Every Wednesday the technician checks the medications in the patient's bedside 
lockers  that have been there for more than 14 days. Insulin, eye drops and intravenous 
liquids are checked in the same way as in the redesign system.
Every night the nurses can print out a list of all drugs that are discontinued and all patients 
that are deceased transferred or discharged. They then collect the drugs from the lockers, 
put a label on it, document why it is taken away and send it back to the pharmacy. 
All drugs have to be returned to the pharmacy and relabelled before the patient can collect 
them for discharge.   
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1.8 Process map to compare medicine supply systems
There are many processes that need to be known and followed of all staff to ensure that 
supply of medicines are working properly. This includes medicines ordered from the wards 
and delivery from pharmacy, but also procedures when the pharmacy is closed and when 
medicine is not available at the ward. 
To identify differences between supply systems, a process map can be used. The map 
shows  what  kind  of  different  outcomes  that  can  occur  after  a  row of  processes  and 
situations,  and  how  this  should  be  handled.  Often  the  processes  are  broken  up  by 
questions  about  the  situation,  and  the  following  procedures  will  be  decided  from the 
answers. The answers are normally yes or no, but there can be several solutions and 
possibilities for how to handle each situation that may occur. 
1.9 Clinical setting
1.9.1 The surgical orthopaedic ward
The first ward included in this study is the surgical orthopaedic ward at Ayr Hospital. There 
are room for 36 patients in total at the ward witch are mostly occupied, and the turnover of 
patients varies from day to day, from 3-7 patients approximately. Normally the patients stay 
at the ward for 5-7 days, but in some cases they leave the same day, and in other settings 
they might need to stay for several months. 
The patients admitted to the ward are having both minor and major operations, from small 
fractions  to  hip  replacements.  The  procedures  can  be  planned  long  time  before 
admissions, or the patient can come from the emergency admissions to the ward. In the 
post operative period the patients stays in a post-up room for recovery, before they are 
moved to one of the other rooms. 
The supply system that is used on this ward is Medicine Redesign System as described 
above, and technicians are supplying the ward every day during the weekdays. The ward 
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is also seen by a pharmacist every day during the weekdays. 
Messages from nurses about  what  changes they think  needs to  be  performed with  a 
patients medicine regime, such as change of route of medicine, is given verbal to doctors 
and pharmacists at the ward. 
1.9.2 The surgical vascular ward
The second clinical setting for this project is the surgical vascular ward at the Ayr Hospital. 
This is the only surgical vascular ward in Ayrshire and Arran. There are 28 beds, and 
approximately 90 per cent of them are occupied at any time. In general the patients can 
stay at  the  ward  from one  day to  10  months,  and  the  turnover  is  approximately  2-3 
patients. Cases of patients staying at the ward for over a year have been seen. 
Even if the ward is considered a surgical ward, not all patients are admitted of this reason. 
There  could  also  be  medical  reasons  such  as  medicine  investigation  and  palliative 
treatment.  Many are admitted to receive wound management,  and social  imputes can, 
according to the nurses working at the ward, infect how long the patients stays at the ward. 
The ward are supplied of medicines from the hospital pharmacy twice a week (traditional 
top  up)  and  most  of  the  time  it  is  the  nurses  who  order  all  needed  medicine,  not  a 
technician as at the orthopaedic ward. 
A handwritten system is used at the ward where the nurses write all  messages about 
possible changes that needs to be done with the patients medicine regime from what they 
experience during administration of medicines. 
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2 The Project – aim and objectives 
2.1 Aim
The aim of the project was to compare two medicines management systems in surgical 
patients in terms of; (1) the nature and the incidence of medicines dose omissions; and (2) 
the relative safety risk from assessment of clinical impact of the omissions.
2.2 Objectives
 Review the NHS literature on risks to patient safety of errors in medication use in 
the peri-operative period. Review the literature on hospital medicines management 
systems.
 Identification of recommendations about medications which should or should not be 
withheld in the peri-operative period.
 Interrogate  the  HEPMA system prospectively to  identify  recorded reasons for  a 
dose  omission.  Dose  omissions  recorded  as  ‘Unavailable  Medicine’ will  be 
confirmed from inspection of the medicines room.
 Design a template to summarise anonymously the clinical context for each patient 
that is the subject of a subset of dose omissions. [The subsets are  ‘Unavailable 
Medicine’, ‘Fasting Patient’, ‘Theatre’, and ‘Unable to swallow’]. 
 Evaluate the clinical significance of the subset of dose omissions at both individual 
drug and individual patient levels, using an expert group of four clinical pharmacists 
 Describe  in  detail  using  a  process  map  (flow  diagram)  the  two  medicines 
management systems and compare the findings.
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 Develop guidelines to help inform ward staff about medicines that should not be 
omitted. Validate the guidelines through group interview with pharmacy and nursing 
staff.  
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3 Methods                          
The project was designed as a prospectively study performed to observe two surgical 
wards  supply systems and administration  of  medicines.  Reasons and quantification  of 
dose omissions were identified before clinical significance of omissions causing harm to 
the patient were decided for a selection of the findings. The results were used to compare 
the two wards and target where improvements might were needed.
3.1 Ethical approval
Before starting up with the project an application was sent to Ayrshire and Arran Health 
Board Ethics Committee, which approved the study 14.01.09.
3.2 Review of literature
Background literature was obtained from research in the electronic library databases Med-
line and Embase. Both MeSH terms and free text were used to find articles on the different 
objects covered in the introduction. Google was a good supplement to help include articles 
that was not found through the sources mentioned above. The reference lists from differ-
ent articles was also used to identify other articles about the same object. 
Several web-sites of the health and pharmacy services in the UK and journals not on Med-
line (Pharmaceutical journal of Pharmacy practice) were browsed to find literature to be 
used in the introduction and for the researcher’s background knowledge. This included 
both the historical and the current health situation in the UK and Scotland, medicines man-
agement systems and the changes that are in progress. Some of the most used web sites 
were The NHS (both England and Scotland), The Scottish Government, The Pharmaceut-
ical Journal, The Royal Pharmaceutical Society of Great Britain and the Audit Commission. 
Some literature items were also accessed at The Ayr Hospital, such as standard operative 
procedures, different articles about medication in the peri-operative period, and the study 
37
about electronic prescribing performed at the hospital.
To identify use of medicines in the peri-operative period, the ‘Guidelines for the manage-
ment of drug therapy in the pre-operative period’ made by Area Drug & Therapeutics Com-
mittee of NHS Ayrshire & Arran was used2. This is the set of guidelines that the phar-
macists and other medical staff use at The Ayr Hospital for what medicines witch should or 
should not be given in the time around surgery. Other sources have also been used, such 
as articles from the Pharmaceutical Journal, and other articles from different NHS hospit-
als as a supplement to those guidelines. 
3.3 Data collection of frequency and reasons for dose omissions
3.3.1 Pilot phase
A pilot phase was performed before the actual data collection to develop and test different 
templates that were used in the actual data collection. The pilot phase lasted for one week 
and gave an idea of what numbers the investigator could expect from the different wards. 
An approximately time for about three weeks was set to be an ideal collecting period, but 
with room for change. 
3.3.2 Data collection 
Data were collected from all patients at the orthopaedic ward from 26th of January to 15th of 
February and from the vascular ward from 13th to 19th of February and from 13th to 26th of 
March. 
The patients prescribed and administered medicines were viewed from accessing each 
patients medicine records at the EPMA system. Frequency and reasons for omitted doses 
were collected by both looking at  history for  each medicine prescribed and the log of 
medicines administrated the last  24 hours.  The two wards where checked for  omitted 
doses at the EPMA system twice a day on the weekdays, about 9 in the morning and 1 in 
the afternoon. Omitted doses from afternoon and evening administration were recorded in 
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the morning the next day, while data from the weekend were collected Monday morning. 
Medication that  was investigated in this  study included  regular  medication, intermittent 
infusions,  continuous  infusions  and  injections.  As-required  medication  (PRN)  was  not 
investigated. 




 Unable to Swallow
 Absent from Ward
 Refused
 Withheld
 IV access unavailable
In some cases the patients were away from hospital and self-administered the medicine 
for a while, and such doses were excluded from the data collection. Other reasons that 






 Not charted prior to discharge
 Transferred patient
3.3.3 Identification of administration issues and patterns
For the medicines recorded as unavailable an investigation was performed to confirm that 
the medicines actually were unavailable and if they were stock items or not.
An overview of when all medicines had been sent to the wards from the pharmacy could 
be seen through the EPMA system or through notes filed by the pharmacy staff (covered 
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both time and date). 
The actual stock amounts could also be viewed in real life from the medicine room, in 
trolleys  and  in  the  patients  bedside  lockers.  This  was  showed  to  be  easier  at  the 
orthopaedic ward, because there was a technician at the ward each day with access to all 
cupboards and trolleys. The nurses were not suppose to be bothered about this, because 
one of the main points was to avoid to interfere the normal routines to the staff and in that 
way get more reliable results. Observations at the vascular ward were therefore narrowed 
(technician  present  two  days  a  week),  but  delivery documentations  were  used  at  the 
omitted, unavailable doses that could not be observed.
To look for similarities of when medicines were recorded as unavailable, the omitted doses 
in this category were divided into weekdays and weekends. The omitted medicines were 
compared with medicines on stock to identify alternatives that the nurses could have given 
the patients instead of omitting the dose.  
3.4 Collection of clinical context of patients with dose omissions
3.4.1 Inclusion of patients 
Each patient in the mentioned time period that had one or more omitted doses in the four 
categories  ‘Unavailable  Medicine’,  ‘Fasting Patient’,  ‘Theatre’,  and ‘Unable to  Swallow’ 
was picked out. Nurses at the two stations where asked about the patients condition to 
find out if the patients would be fine to talk to. Patients thought to be confused, suffering 
from dementia or other similar problems were not included in further data collection. 
Only the patients who did not get excluded in that step, were asked if they wanted to take 
part in the study. Written information was handed out (Appendix 1) which they got time to 
read  trough.  Then a  consent  form (Appendix  2)  had  to  be  signed  before  any further 
information were collected. If the patient had any difficulties with writing, but still wanted to 
take part, a verbal consent was taken. If the patient did not want to take part, this was 
respected and no clinical information was collected. 
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3.4.2 Collection of clinical information about the patients
A template (Appendix 3) was designed to summarise the clinical context for each patient. 
The template contained the patient’s age, sex, presenting complaints, planned or emer-
gency surgical procedures, medical history, current medicines and reported omitted doses. 
All the information was collected in an anonymous form, but coded so that there was a 
possibility to track the actual patient if later questions needed to be addressed. A list with 
the patients’ names and patient number was kept separately in the hospital at all times. 
None of the information was collected if the patient did not give their consent. 
The information  was collected  both  from the  EPMA system and from the  handwritten 
journals. Pharmaceutical care plan and details of the medicines use and omissions was 
found from EPMA, witch also provided surgical procedures, some presented complains 
and medical history. In the handwritten journal a full medical history could be found, details 
around surgical procedures, presented complains and the patients’ biochemical tests.   
The date for each patient’s admission to hospital and how many doses that were already 
given before the omissions occurred were also found to be important information, and this 
information was also collected from the EPMA system. 
   
3.5 Evaluation  of  clinical  significance  of  dose  omissions  by  an  expert  
group
After the collection of the clinical information all patients from both wards were mixed an-
onymously, but still with possibility to track their identification. They were sorted after what 
medicine groups the omissions belonged to, with similar cases following each other. One 
patient after another was then introduced to a group of clinical pharmacists considered as 
experts. Their job was to decide the clinical significance of each omitted dose the patients 
had suffered from. They all got one handout each of all the patient cases, witch gave them 
time to read through it and go back to compare cases during the meeting. 
Two meetings were held with expert groups. The first one was to agree on the categorisa-
tion system chosen for clinical significance because it had not been used or validated be-
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fore.  Nine clinical  pharmacists  where present  at  the meeting,  and the agreement was 
made after looking at 10 different patients. At the second meeting the expert group was 
narrowed to four clinical pharmacists which categorized the 34 remaining patients. The 
meetings lasted for approximately one hour each.
Assessment of clinical significance of dose omissions was set to be:
0 No threat to patient care
1 Minor disturbance to symptom control
2 Major disturbance to symptom control
3 Major threat to stability of patient’s condition
4 Potentially able to precipitate a life threatening event
These categories were devises by the research group after the investigator had checked 
the literature and found no suitable alternatives. 
3.6 Comparison of  two medicine  management  systems using a process 
map
 
The two different medicine management systems used at the two wards investigated in 
this project were described and compared with use of a process map. 
Information about the supply systems were collected by the researcher through direct ob-
servations by following the technicians work processes in the hospital pharmacy and on 
the different wards, especially the wards included in this study. Participation on administra-
tion rounds with  nurses were also performed and supplementary information collected 
from pharmaceutical and nursing staff were also useful to get the total overview of the pro-
cesses both in practice and theory. 
3.7 Development and validation of guidelines 
From the results collected from the expert group analyses, guidelines were developed to 
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identify medicines that should not be omitted. The guidelines were based on the omitted 
doses potentially to cause more than a minor disturbance to symptom control. 
The guidelines were presented to the same expert group that was used for scoring the 
clinical significance at the second expert meeting. Written handouts were given to each 
pharmacist and verbal explanations were also given from the researcher were needed. 
Evaluation  and  approval  were  given  to  the  researcher  after  discussions  between  the 
pharmacists.
Unfortunately  the  last  object  where the  guidelines  should  be  validated  through  group 




4.1 Quantitative description of dose omissions 
A  total  of  9614  doses  of  medication  were  prescribed  to  hospital  inpatients  in  the 
orthopaedic ward and 8245 doses to the patients in the vascular ward over the 3-week 
period (excluding medicines prescribed on an as-required basis). Of these, 972 (10.1%) 
and 492 (6.0%) doses were  omitted  in  total  respectively.  Most  of  the omissions  were 
caused by patients refusing and doses being withheld at both wards. 
The breakdown of the omitted doses into omissions per day at the two wards are shown in 
appendix  5  and  6,  and  show  both  counts  and  percentages  of  the  total  amount  of 
prescribed doses. 
The  following  two  tables  show  the  frequency  of  dose  omissions  of  different  reason 
compared at the orthopaedic and vascular ward. The comparison is presented both from 
the total number of doses prescribed, and the total number of omitted doses.  
The confidence intervals per proportion presented in the tables shows that there is a 95% 
chance  that  the  proportion  of  dose  omissions  would  be  in  this  interval  if  data  were 
collected again using the exact same methods. A visual check of overlapping between one 
proportion and the interval of the other proportion can give an approximately idea if there is 
a significant difference. If overlapping is seen, a significant difference is unlikely. The visual 
test does not replace proper statistic test calculating p-values.   
The p-values were found using Chi-square with Yates correction when comparing omitted 
doses to the total number of doses, and Fischer exact test for comparison with the total 
number of omitted doses, because Chi-square works better with high numbers. The p-
values denote if there are any significant differences between the two wards. If this value 
is equal or over 0.05 there is no demonstrable difference between the two wards, while a 
p-value under 0.05 means that there is a 95% likelihood of a real difference between the 
two wards based on the comparison of the two samples. The closer the p-value gets to 
zero, the greater are the percentages of the likelihood of difference.
45
Table 3.  Comparison of dose omissions from total number of doses that should have been given on the Orthopaedic 
(n=9614) and the Vascular ward (n=8245) 
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Table 4.  Comparison of dose omissions from total number of omitted doses on the Orthopaedic (n=972) and the Vascular 
ward (n=492) 
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(0.4) 0.1, 1.1 
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(1.4) 0.6, 3.0 0.05
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Figure 1 The frequency of different reasons for omitted doses of the total number of doses 
prescribed
Figure 2 The frequency of different reasons for the total amount of omitted doses
The high number of  refused doses were especially notable,  and after  the observation 
period it could be concluded that the laxatives lactulose and senna stood for 284 of the 
517 (54.9%) omitted doses in this category at the orthopaedic ward, and 57 of 167 (34.1%) 
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4.2 Dose omissions categorized as unavailable 
There was a higher frequency of doses charted as unavailable at the orthopaedic ward 
than at the vascular ward (0.8% and 0.5% respectively, p = 0.02). The data collection also 
showed that  38.2% (orthopaedic  ward)  and  46.3% (vascular  ward)  of  the  unavailable 
medicine were right before (7am dose) or within the pharmacy opening times, included the 
three hours the pharmacy is opened at Saturdays, and 61.8% and 53.7% respectively 
were outside the pharmacy opening times. 
Inspections of the time for supply of the medicines and observations at the wards showed 
that 51.3& (orthopaedic ward) and 39.0% (vascular ward) were present at the ward at the 
time the dose was noted as unavailable.  These numbers are not  statistical  significant 
different (p = 0.34).
Of the doses noted as unavailable at the orthopaedic ward there were 16 doses that were 
stock items and 14 of them were on the ward. For the vascular ward, 6 doses were stock 
items, and 5 of them were on the ward, (p= 0.46 not statistical significant different).
Of alternative medicines that were available at the wards at the point of doses omitted and 
recorded as unavailable there were 4 doses at the orthopaedic ward, and 1 dose at the 
vascular ward.  
Table 7 Frequency of medicine found on the ward after recorded as unavailable.




n % n %
Total 76 41
On ward 37 51.3 16 39.0 0.34
Not on ward 39 48.7 25 61.0
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Table 8 Locations of omitted doses noted as unavailable, but identified as available 
at the orthopaedic ward.
Frequency omitted doses
Medicine room 3





Table 9 Frequency of stock items noted as unavailable
Orthopaedic ward Vascular ward
Unavailable 
doses




Stocked 16 21.1 6 14.6 0.46
Non stocked 60 78.9 35 85,4
Table 10 Medicines on stock that could have been given as a supplement 
Unavailable dose Available supplement Notes
Orthopaedic ward Amoxicillin 500mg caps Amoxicillin 250mg caps Happened 2 times
Diclofenac 75mg in 2ml 
inj.
 Diclofenac 75mg in 
3ml inj.
Propranolol 80mg mod. Propranolol 40mg mod.
Vascular ward Senna 7.5mg in 5 ml 
syrup
Senna 7.5mg tablets If the patient did not 
have troubles 
swallowing
Unavailable medicine in weekends compared to weekdays
The number of unavailable medicine in the weekends were much higher in the orthopaedic 
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ward than at the vascular ward, 1.2% and 0.2% respectively, compared to the total amount 
of prescribed doses (p= <0.0001) and 12.5% and 4.2% compared to the total number of 
omitted doses (p= 0.01). Data was collected from three weekends and included all doses 
given Saturday and Sunday. 
The number of unavailable medicines during the weekdays was the same in percentages 
at the two wards compared to the total number of doses prescribed at each ward (0.6%). 
But compared to the total number of omitted doses during weekdays, the percentages of 
unavailable medicine was higher in the vascular ward than the orthopaedic ward, 9.7% 
and 6.1% respectively (p= 0.04). 
Table  11  Frequency  of  omitted  unavailable  doses  (n)  of  the  total  number  of 
prescribed doses in weekdays and weekends, compared between the two settings 














9614 76 8245 41
Weekdays 6964 44 (0.6) 0.5, 0.9 5983 36 (0.6) 0.4, 0.8 0.92
Weekends 2650 32 (1.2) 0.8, 1.7 2262 5 (0.2) 0.1, 0.6 <0.0001
Table  12  Frequency  of  omitted  unavailable  doses  (n)  of  the  total  number  of 
omissions in weekdays and weekends, compared between the two settings 














972 76 492 41
Weekdays 717 44 (6.1) 3.4, 6.1 372 36 (9.7) 5.3, 10.1 0.04
Weekends 255 32 (12.5) 2.3, 4.7 120 5 (4.2) 0.4, 2.5 0.01
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4.3 Collection of clinical context of patients with dose omissions
4.3.1 Inclusion of patients
In total 76 patients experienced omitted doses caused by one or more of the four different 
categories, ‘Unavailable Medicine’, ‘Fasting Patient’, ‘Theatre’, and ‘Unable to Swallow’,  
which was sat to be the first inclusion criteria during the collection period. There were 51 
at the orthopaedic ward, and 25 at the vascular. Consent was received from 44 of the 
patients, 32 from orthopaedic and 12 from vascular. 
All together 32 patients did not give their consent. Some patients were too ill or suffering 
from dementia or other things that made them unable to give consent. There was also a 
few that after hearing about the study decided that they did not want to take part. 
Unfortunately there were also some cases where the patients had left the hospital before 
consent had been given. Of this, 4 had received written information, but were gone when 
the  researcher  came to  get  consent,  and 3 had left  the  ward  while  data  was being 
collected from other patients.
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Patients not included in the study :
Declined: 3
Unable to give consent: 15
Missed by researcher : 1
Patients who gave their consent : 
32
Patients with omitted doses in the 
4 categories : 51
Patients with omitted doses in the 
4 categories : 25
Patients not included in the study :
Declined: 2
Unable to give consent : 5
Missed by researcher*: 6 
Patients who gave their consent : 
12
Total number of included 
patients in the study : 44
Figure 3 Inclusion of patients for collection of clinical context.
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4.3.2 Description of the patients included in the study
Of the 44 patients included in the study there where several who had just one or two 
omitted doses during the data collection period, but there where also cases of patients 
who had over  ten  omissions.  The highest  number of  omitted  doses that  one patient 
experienced  during  the  collection-period  happened  at  the  vascular  ward  and  was 
calculated to 31. The average number of dose omissions for each patient was 4 at the 
orthopaedic ward and 5 at the vascular ward. The average age of the patients included in 
the study was approximately 67 years at both wards, and in both wards there were more 
women, 78.1% at the orthopaedic ward, and 66.7% at the vascular ward. 
The data collection showed that the main cause for admissions to the two wards among 
the included patients were planned or emergency surgeries, 78.2 %  at the orthopaedic 
and 50.0% at the vascular ward. There were also other reasons for admission recorded. 
At the vascular ward these were mostly patients with ischemic arms or legs who needed 
wound treatments. For patients admitted to the orthopaedic ward it was patients who had 
fractions and other injuries after fall, while others complained about pain in knees or hips 
from other reasons. 
Table 13 Description of the patients included in the study (n=44)
Orthopaedic 
ward 
Vascular ward Total p-value (Fischer’s 
exact test)














































Figure 4 The frequency of omitted doses per patient who was included in the study
4.4 Scoring of  clinical  signification of  the omitted doses by the  expert  
group
4.4.1 The expert group's validation of the study design 
Because the assessment used in this study had never been tried out before, the meaning 
behind the different outcomes were discussed during the expert group meetings, and 
cases were sometimes compared against each other to find the correct score to each 
case. The expert group found the gaps between 'minor disturbance to symptom control', 
'major disturbance to symptom control' and 'major threat to stability of patient’s condition' 
a  bit  too  wide.  In  some cases  the  expert  group  thought  the  possible  outcome  was 
between to scores, and had to settle with one of the outcomes. 
In most of the cases the pharmacists thought they had enough information to score the 
dose omission, but in some cases they had to do some assumptions. The most important 
lack of information was that the messages from the anaesthetists about what medicines 
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that should or should not be given were not collected. They decided to follow regular 
guidelines instead and normal procedures for withhold of medicines as they would have 
done it in practice. In the end all the four pharmacists had agreed with the mean scores 
that were set for each omission.
4.4.2 Scoring of clinical significance
In total 189 omitted doses occurring in 44 patients were presented to the expert group for 
decision of clinical significance. In total 41.2 per cent of the omitted doses potentiall could 
have caused some kind of disturbance to system control, (28% minor disturbance and 
13.2% major). 
In one of the cases scored as ‘major disturbance to symptom control’ the pharmacists 
were  in  doubt  if  it  should  have been scored as  ‘major  threat  to  stability  of  patient’s 
condition’. This was a medicine used for preventing thromboembolism, and will be further 
presented under the section about cardiovascular medicine. 
There were no cases of omitted doses scores as ‘potentially able to precipitate a life 
threatening event’.
56
Table  14  Comparison  of  the  division  of  clinical  significance  of  omitted  doses 











No threat to patient 
care 72 (56.3) 39 (63.9) 111 (58.7) 0.35
Minor disturbance to 
symptom control 37 (28.9) 16 (26.2) 53 (28.0) 0.73
Major disturbance to 
symptom control 19 (14.8) 6 (9.8) 25 (13.2) 0.49
Major threat to stability 
of patients condition 0 (0.0) 0 (0.0) 0 (0.0) -
Potentially able to 
precipitate a life 
threatening event
0 (0.0) 0 (0.0) 0 (0.0 -
Total number of 
omitted doses scaled 
for clinical significance
128 61 189
4.4.3 Clinical significance of omitted doses in different medicine groups.
The omitted doses were divided into 15 different medicine groups after the guidelines for 
withheld  or  continuation  of  medicines  in  the  peri-operative  period12.  Cardiovascular 
medicine alone stood for 27.5 per cent of all the omitted doses scored, and there were 
also many doses omitted in the medicine groups “nutrition and blood”, gastrointestinal 
and analgesia, 14.8, 10.6 and 10.1 per cent respectively. 
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Table  15  Frequency  of  clinical  significance  of  omissions  (n=189)  in  different 
medicine groups 









Medicine groups Frequency (% of total amount of scored omitted doses in each 
scoring category) 
Gastrointestinal 11     (9.9) 7     (13.2) 2     (8.0) 20     (10.6)
Cardiovascular 12     (10.8) 30     (56.6) 10    (40.0) 52     (27.5)
Respiratory 3       (2.7) 2     (3.8) 5     (2.6)
Central nervous 
(CNS)
9       (8.1) 9     (4.8)
Infections 6     (11.3) 9     (36.0) 15     (7.9)
Endocrine 8       (7.2) 4     (16.0) 12     (6.3)
Obstetrics, 
gynaecology and 
urinary tract disorders 4     (7.5) 4     (2.1)
Malignant disease and 
immune suppression 3     (2.7) 1     (1.9) 4     (2.1)
Nutrition, blood 28     (25.2) 28     (14.8)
Musculoskeletal and 
joint diseases
6     (5.4) 1     (1.9) 7     (3.7)
Topical steroids 2     (1.8) 1     (1.9) 3     (1.6)
Antihistamines 4     (3.6) 4     (2.1)
Drugs used in nausea 
and vertigo
2     (1.8) 2     (1.1)
Analgesia 19     (17.1) 19     (10.1)
Others 4     (3.6) 1     (1.9) 5     (2.7)
Total 111     (58.7) 53     (28,0) 25     (13.2) 189 
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Figure 5 Clinical significance of the evaluated, omitted doses and comparison of medicine 
groups. 
Four groups of medicines represent cases where omitted doses have caused a potential 
‘major  disturbance  to  symptom  control’,  which  were  the  groups  gastrointestinal, 
cardiovascular, endocrine and infections. 
Gastrointestinal 
Most of the medicines in this group where thought to not cause any harm to the patient if 
omitted, like lactulose and senna. But there where two cases where the patient did not 
receive the prescribed H2- antagonist in front of the operation, and both of them were set 
to be able to cause ‘major disturbance to symptom control’ by the expert group. The 
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prevent stomach regurgitation during anaesthetic which can cause pulmonary aspiration. 
In both of the cases the surgery was planned.
Cardiovascular
In total 10 of 52 omitted doses in this medicine group were set to score major disturbance 
to symptom control. Of them there were 6 cases of omission of beta blockers in the peri-
operative period, and the risk for withdrawal effect and consequence of stress hormones 
on the unmasked beta-adrenoceptor system13 were confirmed by the pharmacists who 
scored the clinical significance of this medicines. 
The right treatment for preventing bleeding during and VTE after surgery is a complicated 
task that must be followed like prescribed to prevent harm to the patient. Aspirin is often 
stopped 7-10 days before surgery, if bleeding risk is significant12, and omissions like this 
were scored as no threat to patient care. But on the other hand, if aspirin is omitted after 
surgery the patient looses critical  treatment against VTE, and the clinical pharmacists 
scored the cases of this the same as they did with the beta blocker. The same was also 
seen in a case where the patient did not get heparin in the nil by mouth period before 
surgery. 
The last case within the cardiovascular medicines was the only case during the expert 
meetings were the pharmacists were uncertain if they should score a omitted medicine 
as  ‘major  disturbance  to  symptom  control’  or  ‘major  threat  to  stability  of  patients 
condition’. This was a case witch also included treatment to prevent VTE. The pharmacist 
had decided that the patient should receive the medicine rivoroxaban straight after the 
procedure. This dose was omitted and not given before the next day. What was special 
about this situation was that the patient had pulmonary embolism among her medical 
history and was therefore in a greater risk of experience thromboembolism. 
Endocrine
There  were  three  cases  were  patients  had  not  received  their  regular  dose  of 
prednisolone in the nil by mouth period. All three were scored as possible to cause ‘major 
disturbance  to  symptom  control’.  The  expert  group  concluded  that  patients  using 
prednisolone regularly should not have any omitted doses of this medicine at any time in 
the  peri-operative  period,  because  of  the  great  stress  factors  that  the  patient  may 
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experience during this time.  
Infections
All of the doses against infections were thought to cause some kind of disturbance to 
system control if omitted. Nine out of fifteen doses were scored as major, and six were 
categorized as minor. The choice of categorization of clinical significance depended on 
what the medicine was against, how serious the infection was and for how long time the 
patient had received the treatment before the dose was omitted. 
Doses of antibiotics omitted late in the numbers of doses given to the patient were scored 
as minor disturbance. There were five different clinical settings for this. There were also 
two cases were the first dose was omitted, and one with the second dose and they were 
all set to be of major disturbance to system control. There was also a case were the 4th 
dose was categorized like this, and this was an injection given against a wound infection.
Another case of treatment of infections was a woman with MRSA, who missed both a 
dose of Mupirocin Nasal Ointment 2% and Stellisept med foam. Both omitted doses were 
set to be potential to cause major disturbance to symptom control. 
 
There were three cases were antifungal medicine were omitted, and they were all set to 
cause  some  kind  of  disturbance  to  symptom  control.  These  medicines  were  just 
prescribed as cures for 2-3 days with one dose a day, and if one of these where omitted 
the pharmacists in the expert group concluded that the meaning with the treatment was 
disturbed.   
Medicine classified as ‘No threat to patient care’ 
As can be seen in table.. there were most cases of omitted doses categorized as  ‘No 
threat to patient care’  at both wards, in total 56.3% and 63.9% on the orthopaedic and 
vascular ward respectively. 
Even if the clinical history of the patients varied, there were some medicines that were 
set in this category every time, such as the laxatives lactulose and senna (omitted 6 and 
3 times respectively). The analgesic paracetamol was omitted 17 times, and were also 
classifies as no threat. The reason for this, according to the expert group, was that the 
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patients received other stronger analgesic and would not notice any differences when 
these doses were omitted. Cholesterol lowering medicines, antihistamines and vitamins 
were other medicines also were scored as no threat to patient care in several settings.   
4.5 Guidelines to help inform ward staff about medicines that should not be 
omitted.
From the scoring of clinical significance by the expert group, there were 7 medicine groups 
that were concluded as medicine that should not be omitted for any reason. These were 
the  medicines  scored  as  potential  to  cause  ‘major  disturbance  to  symptom control’  if 
omitted.  Some of the medicines must not be omitted at any time during the peri-operative 
period, while others are more important either in front of or after surgery. The exceptions 
are if the anaesthetist has given other instructions or if it is clinical inappropriate to give the 
dose. 
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Table 16  Guidelines for  medicines that  can not  be omitted in  the peri  operative 
period for any reason, except if the anaesthetist have given other instructions or if 
clinical inappropriate.
Medicine group Some examples of 
medicines
Time period
H2 antagonist Ranitidine Before surgery
Beta blockers Metoprolol, propranolol, 
carvediol, atenolol
Before surgery and 4 days 
after
Antiplatelets Aspirin, dipyridamole After surgery
Anticoagulants Rivoroxaban After surgery
Dalteparin Peri-operative period (before 
and after)
Corticosteroids Prednisolone Peri-operative period (before 
and after)






Any time (especially first to 
fourth dose).




4.7 Process map comparing the two supply systems for clinical setting 





Represents the first and 
last step of process
Represents a step in a 
process (activity or task)
A question with a Yes or 
No answer
An arrow that connects 
the different boxes in the 
process map
Figure  6 Symbols used in the process map
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New prescriptions,
  medicine already in 
use and stock items
Medicine on 
ward?
The patient receive 
all medicine he or she is 
prescribed
Is the technician on the 
ward? (2 times a week, 
topping up stock items 
and using list from 






Nurse borrow medicine 
from other wards or pick 
up medicine from 
emergency room






























order next day from 
pharmacy or 
directly from other 
suppliers 
Pharmacist check EPMA from 
home if the medicine is at the 
hospital, open pharmacy for 
dispensing medicine if not or 
order medicine from 
Crosshouse Hospital or 
directly from suppliers 
Yes
No Nurse at ward informed
Figure 7 Process map for The Traditional Top Up supplying system
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Pharmacist check EPMA from 
home if the medicine is at the 
hospital, open pharmacy for 
dispensing medicine if not or 
order medicine from 
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5 Discussion
5.1 Data collection 
5.1.1 Validation of use of EPMA to collect data
All findings from the data collection of reasons for omitted doses were found using the 
electronic computer system within the hospital. It was shown to be a precise and reliable 
method of finding information, from both present and former time. This was both because it 
was easily accessible from computers at both the wards and within the pharmacy, and 
because the history of a patient was possible to find even if the patient was discharged.   
Because the nurses have to document the reason for why a dose has not been given into 
the system, there were no unknown results, witch were very convenient for the reliability of 
the numbers collected. 
But at the same time the EPMA system allows the nurses to wait with documenting the 
reason  for  each  omission  until  the  next  dose  is  due.  This  makes  it  possible  for 
documentation to be performed by another person than the original administrator. In these 
cases there is a possibility for wrong documentation. Even if the nurse who was in charge 
for the administration went back to document the reason, the actual reason could have 
been forgotten.  A change in the electronic system at this may not manage to reduce the 
number of dose omissions, but it would make studies like this more reliable. 
5.1.2 Validation of reasons documented for omitted doses 
Because direct observation were not performed in all  part of this study, it is difficult  to 
validate the reasons collected for dose omissions. Information from the anesthetists about 
individual treatment in the fasting and postoperative period were not collected in this study, 
and limits the conclusions of the number of omitted doses in the categories 'fasting patient' 
and 'patient in theater'. Either the time for the patients surgeries nor the reason for the 
patients fasting were documented, and this lack of information makes it difficult to say if 
any of the omitted doses in the category 'fasting patient' could have been avoided or if they 
were withheld for a clinical reason. 
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For the reasons  'patient unable to swallow' and 'IV access unavailable' alternative route 
should have been used, and a pharmacist should be informed. It was possible to identify 
through the EPMA system that doses charted as these two reasons were not given in any 
other route, but because direct observation of these settings were not performed, it is not 
possible to say if the pharmacists knew about the situations or not. 
But in some cases there were reasons to believe that the reason documented possibly 
could be wrong, such as one case when a patient received all medications except from 
one, and this dose was recorded as “patient absent from ward”. There were also many 
omitted doses recorded as unavailable, but found on the wards medicine room, in trolleys 
or in the patients own bedside lockers at inspection. This questioning if the procedures that 
should be followed when a medicine is not found may not be performed in reality in every 
case.
The possible reasons for these happenings include that the nurse may write the wrong 
reason for dose omission as a mistake, or that the nurse looked for the medicine, but could 
not find it. This could be because the medicines were not looked for properly or because 
the medicine were not at the place where they should have been. 
5.1.3 A comparison of the two clinical settings 
The higher number of omissions in total at the orthopaedic ward compared to the vascular 
ward  was  caused  by  the  reasons  'refused',  'fasting  patient', 'patient  in  theatre' and 
'unavailable medicine'. 
The reasons for dose omissions recorded as 'fasting patient' and 'patient in theatre' being 
higher at the orthopaedic ward is probably because of the main reasons why patients are 
admitted to the two wards. In the vascular ward procedures are less common, and many 
patients are just receiving wound management and medical investigation before they are 
going home, while most patients in the orthopaedic ward are having surgery. 
The number of refused medicine was the highest number counted of all reasons at the 
orthopaedic ward with 5.4 %, against the vascular ward with 2.0%. The reason for this 
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could be connected to the number of  patients going to surgery,  because vomiting and 
nausea often is a side effect from these procedures and could make the patients medicine 
intake quite difficult and unwanted. The high number of refused doses of lactulose and 
senna at the orthopaedic ward compared to the number at the vascular ward shows where 
the main difference is. 
Doses charted as 'unavailable' 
The orthopaedic ward had a statistical significant higher amount of unavailable doses than 
the vascular ward in total and in the weekends compared to the total number of prescribed 
medicine. The vascular ward had more unavailable doses during the weekdays. Because 
these last numbers is compared to frequencies of other reasons for omitted doses, the 
values would be less usable to draw conclusions with than the numbers that is found by 
comparing the total number of prescribed doses.   
Both  the  number  of  patients  admitted  and  the  turnover  of  patients  is  higher  in  the 
orthopaedic  ward.  New patients  means  new  medicines,  which  are  more  likely  to  be 
unavailable than medicines that the inpatients are already using. This can be one of the 
reasons  for  the  number  of  unavailable  doses  is  higher  in  the  orthopaedic  ward,  but 
because the turnover is not as big in the weekends as it is during the week, there is a high 
possibility that the reason is more complex than that. 
Just a selection of medicines is stocked at each ward, and because patients are using 
their own medicines at the orthopaedic ward, the medicine room do not cover as many 
medicines as the vascular ward. During the weekends the pharmacy is not open except 
from some hours on Saturday morning, and the supply of medicines is therefore narrowed 
in the weekends. But it is important to remember that there are a emergency room with 
medicines that can be used. If this happens in reality were not investigated in the study.
Another aspect is that  the nurses at  the orthopaedic ward with the medicine redesign 
system, are used to having a technician controlling the medicines during the weekdays. 
The nurses at  the  vascular  ward  with  the  traditional  top  up  are  more  involved in  the 
medicine management at the ward during the week, and it might be easier for them to 
control this in the weekends when the technicians are away.
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Doses charted as 'absent from ward'
The reason 'absent from ward' was statistically significant different between the two wards 
(<0.0001), and the vascular ward scored highest at this result. The numbers were quite 
small at both wards, 0.04% and 0.2% of the total numbers of prescribed medicine at the 
orthopaedic  and  vascular  ward  respectively  and  a  visual  test  shows  that  the  95% 
confidence intervals is almost covering each other. In Appendix 4 the frequency of different 
reasons for dose omissions per day can be seen, and it shows that 14 of the total 16 
omitted  doses  documented  as  'absent  from  ward'  happened  at  the  same  day.  The 
reliability of the difference between the two wards for this reason is therefore narrowed, 
because the result would have been completely different if this day had not been included. 
Doses charted as withheld
The number of withheld is statistic significant higher at the vascular ward. The reason 
could be the routines they have for categorisation of omissions, but it is difficult to make 
any conclusions without direct observation of the administration.
5.1.4 Comparison to earlier studies
To compare the results from this study to earlier studies the setting and method should 
ideally be the same. Of the studies from the UK both total number and reasons for dose 
omissions varies. The reasons for this could be:
 different methods
 direct observations (researcher is present at dose administration)
 information collected from patient drug charts prospectively
 other staff collected information witch the researcher received 
 different settings (type and size – some studies from on single ward, others from 
several hospitals)
 time- period difference
 inclusion  of  reasons  for  dose  omissions  (some  have  excluded  the  numbers  of 
clinical reasons for omissions)
The  study  performed  at  Ayr  Hospital  in  1997/19984,5 had  both  the  same  setting  and 
method, and showed that both total number of omissions and unavailable medicine have 
increased. The reason for this are beyond the scope of this study, but a interesting point of 
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view for the important further work on preventing dose omissions.
5.2 Clinical significance of dose omissions 
5.2.1 The possibility of harm caused by a dose omission
The percentages of clinical significance of the omitted doses were scored between  'no 
threat to patient care',  'minor disturbance to symptom control' and  'major disturbance to 
symptom control'. No doses were scored as 'major threat to stability of patient’s condition' 
or  'potentially able to precipitate a life threatening event'.  But because of the following 
aspects it  can not be concluded that single omitted doses are not able to cause such 
events. 
The number of 189 doses used to find these results cover several medicine groups, but 
not nearly all the medicines that can be omitted. For example no medicines used to treat 
conditions in the CNS were scored except from analgesia. There are also a huge unknown 
number of situations that is possible to happen to a patient condition if errors are caused in 
their  medicine  regime.  Individual  differences in  medical  history,  other  medicines  used, 
clinical  setting  and  the  combination  of  these  are  some  of  the  reasons  for  the  wide 
possibilities of outcomes. This was also confirmed by the results from the omitted doses 
scored by the clinical  expert group, because in several cases the same medicine was 
scored different from case to case.  
When patients were included in the study, their conditions were judged by the nurses on 
the ward if they would be okay to give their consent. The patients that were feeling very ill 
were excluded, and it can be speculated if the results could have been different if these 
patients had been included. The reason for this is that one of the scoring criteria for clinical 
significance to an omission is the patients condition, and ill patients could suffer more from 
an omitted dose than a patient that have his or her condition under control in some cases. 
Another  important  point  of  view in  the  validation  of  the  range of  clinical  significance 
scored by the expert group is the fact that the pharmacists thought some of the gaps 
between the scores were to wide. The results of the clinical significance of dose omis-
sions could possibly had a different outcome if there had been a wider categorisation sys-
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tem.
5.2.2 Data collected from the two different settings 
There was no statistic significance between the two wards when it came to clinical signi-
ficance scored by the expert group. But because there was such a small group of pa-
tients collected from the vascular ward, and that one of these patients stood for 51% of 
the scored omissions (31 of 61), it is difficult to say if the same result would be found if 
the same study was performed again. This is because the condition to this patient would 
be important to the outcome of the doses that were omitted. If the same omissions had 
happened to another patient, or a group of patient, the scoring could had differed. 
5.2.3 The scores of clinical significance compared to earlier studies
None of the previous studies presented in the introduction used the same scoring system 
as the new one used in this study. In the study from Queen Elizabeth Hospital clinical7 in-
formation were not collected from the patients and in the study from US a scoring system 
was not used at all. None of the study settings were from a surgical ward either, and all 
this differences makes it difficult to compare the numbers.
From the study at Ayr Hospital in 1997/19984,5 67.4% of the omitted doses were of some 
kind of significance against the 41.2% showed in this study. The reason for this is prob-
ably because the scoring system that was used then had 10 different possible scores 
compared to 5 in this study. If would be easier to categorize a dose omission as 1 when 
the scale is larger.     
5.2.4 Guidelines for doses that should not be omitted
It  is  important  to  inform  nursing  staff  about  the  medicines  that  were  included  in  the 
guidelines from this study, but it is only a start for the complete knowledge the persons in 
charge for administration of medicine should have about all medicines that should not be 
omitted to avoid medicine incidents from happening. This is especially because there is a 
probability that nurses some times make decisions themselves if a dose is okay to omit or 
not when it comes to unavailable medicine. 
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With more complete guidelines there is reason to believe that there would be less room for 
misjudgements. Also if the nurses were trained more about the risk a dose omission could 
cause, the number of omitted doses could probably be narrowed at some points, such as 
the number of omitted doses charted as unavailable but found on the ward.
At the same time it is important to avoid terms as low risk medicines, because even if a 
medicine is not  scored as clinical  significant if  omitted in many cases, there could be 
situations were it could be of great importance. 
5.3  Guidance for repetition of this type of study
As the project proceeded there were some points about the method that could have been 
changed to get more precise and reliable results. Unfortunately there were some issues 
that were discovered to late, as the anaesthetic records not collected for patients with 
omitted doses caused by the reason 'fasting'. Changes that could be done if this project is 
performed again are listed in table..
There could also be many other interesting aspects to discover about  dose omissions 
witch were not included in this study, such as direct observation of the use of alternative 
routes when needed and how procedures work out in practice when the patient is absent 
at the time for medication intake. 
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Table 17 Possible outcomes that changes in the method could have caused





medicine charted as 
unavailable  
Inspection of ward 
when possible during 
weekdays, inspection 
through EPMA of 
medicine on wards 
and medicine sent 
up, confirmation by 
technician 
Researcher could 
had access to the 
medicine cupboards 





More reliable results 
about the actual 
situation of 
unavailable medicine 
at the vascular ward. 
Process maps Observation of 
orders from the 
wards and supply 
from the pharmacy, 
the rest in theory
Observation of the 
further process in 
practice, from a 
medicine is 
unavailable at both 
pharmacy and the 
wards until the 
medicine is received 
by the patient.
 
More results about if 
the theoretical 
process is followed in 
practice




Inspection of all 
medication 
prescribed and used 
by the patient 
charted at the 
EPMA system 
Anaesthetic Records 
used as a 
supplement
Easier for the 
pharmacists to make 
faster decisions of 
the score of omitted 
doses caused by 
'fasting patient'
Collection of the time 
for the patients 
surgeries 
Inspection of the 
patients records
Use the staff at the 
ward to help confirm 
the time
Easier for the 
pharmacists to make 
faster decisions of 
the score of omitted 
doses caused by 
'fasting patient'
Scoring of clinical 
significance
Assessment with five 
scoring categories 
used
Inclusion of 1 or 2 
more categories
A more precise 




The two wards compared in this study had both different and common outcomes when it 
came to  frequency and  reasons for  dose omissions.  The differences  can possibly  be 
explained by the amount of surgeries performed in each ward, the frequency of turnover of 
patients and the use of different medicine supply systems. Because the method used in 
this study did not include direct observation of the administration of medicines, the correct 
reasons  for  dose  omissions  can  not  be  validated  with  the  same  confidence.  The 
conclusions  about  reasons  for  differences  between  the  two  wards  is  also  narrowed 
because of this. But the study gives a good impression of the range and proportion of 
doses that the patients did not receive as prescribed. 
Clinical significance of dose omissions were scored by a new assessment in this study that 
had not been validated before. The expert group thought the gaps between the scores 
were a bit too wide, and the results could possibly had a different outcome if there had 
been a wider categorisation system. The outcomes from scoring clinical significance of 
omissions would possibly also vary by the selection of patients. This is because there are 
many important individual aspects to consider when scoring a dose omission.
The study showed that dose omissions have a quite big possibility to cause disturbance to 
symptom control in the peri-operative period, and some reasons for dose omissions should 
be possible to reduce, such as unavailable medicine. From the clinical scoring of the 189 
omitted doses several guidelines were developed, witch shows that these kinds of audits 
can  contribute  for  possible  reduction  of  omitted  doses.  Further  work  to  create  more 
complete guidelines is one method to get closer to this goal.
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7 Appendices
Appendix 1 Patient information sheet handed out to patient included in the 
study.
PATIENT INFORMATION SHEET
The study of Doses of Medicines not given in Surgical and Medical 
Patients in the Ayr Hospital
You are being invited to take part in a research study.  Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take 
time to read the following information carefully. Talk to others about the study if you wish. 
Ask us if there is anything that is not clear or if you would like more information.  Take time 
to decide whether or not you wish to take part.
What is the purpose of the study?
Sometimes doses are missed in medicines that have been prescribed. There can be lot of 
reasons for this to happen. The aim of this study is to find out the reasons why this 
happens and to try to prevent it happening in the future. 
Two final year pharmacy university students from Norway who are currently working with 
the pharmacists in Ayr Hospital and Strathclyde University will carry out the study. The 
students’ names are Elisabeth Johansen and Kristin Reinaas Lysheim.
Why have I been chosen?
You have been chosen because you have been admitted to the wards that the study is 
taking place, which are Stations 6, 10. 12, 14, 16 during the study time period.
It is hoped we will study a total of about 200 patients during the time period.
Do I have to take part?
No.  It is up to you to decide whether or not to take part.  If you do, you will be given this 
information sheet to keep and be asked to sign a consent form. You are still free to 
withdraw at any time and without giving a reason.  
A decision to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive. 
Patient Information Sheet (version 1)
12/12/2008
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What will happen to me if I take part?
If you decide to take part in this study, your notes and the electronic prescribing system will 
be accessed when you in hospital.  The electronic prescribing system also contains the 
information about which medicines you have received and which ones you have not 
received. This information will be used by the students in the research. 
Any information taken from your notes will be kept anonymous. 
What do I have to do?
You are only required to give permission for the information in your notes to be used as 
part of the study.
You will not have to do anything, complete any forms or visit any clinics or hospitals during 
the study. 
If you decide to take part in the study, you will be asked to sign a consent form. This will 
allow us to access your notes when you are in hospital and use the information in your 
notes. 
After this you will not be asked to do anything else.
What are the possible benefits of taking part?
There are no direct benefits to your treatment by taking part in the study. 
However, if the study produces good results it will give us information on how to prevent 
doses being missed in the future.
This may benefit patients in Ayrshire and Arran in the future.
Patient Information Sheet (version 1)
12/12/2008
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What if there is a problem?
Any complaint about the way you have been dealt with during the study will be addressed. 









If you remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure. Details can be obtained from Ayr Hospital.
Will my taking part in the study be kept confidential? 
Yes.  All the information about your participation in this study will be kept confidential.  
You will be given a copy of the information sheet and a signed consent form to 
keep.
Thank you for taking time to read the information sheet and for considering taking part in 
this study. 
Patient Information Sheet (version 1)
12/12/2008
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Appendix 2 Consent form for the patients included in the study
CONSENT FORM
The study of Doses of Medicines not given in Surgical and 
Medical Patients in the Ayr Hospital
Name of Researchers:  Elisabeth Johansen and Kristin Reinaas Lysheim
         Please initial box
1. I confirm that I have read and understand the information sheet dated
12/12/2008 for the above study. I have had the opportunity
 to consider the information, ask questions and have had these answered
satisfactorily.
2. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without any medical care or legal 
rights being affected.
3. I understand that relevant sections of any of my medical notes and data 
collected during the study, may be looked at by responsible individuals 
from Ayr Hospital pharmacy department. I give permission for these
   individuals to have access to my records.
4.   I agree to take part in the above study.
________________________ ________________ ___________________
Name of Patient Date Signature
_________________________ ________________ ___________________
Name of Person taking consent Date Signature
(if different from researcher)
_________________________ ________________ ___________________
Researcher Date Signature
When completed,  1 for patient;  1 for researcher site file;  1 (original) to be kept in medical notes.
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Appendix 3 Template used to summarise clinical context for each patient  
Patient-information template Station: 10  /  12
Patient-number: Sex:  F  /  M Age:
Presented complains:
Emergency or planned surgery:
Medical History: Drug history:
Current drugs:
Name, Form, Route (specify if not oral) Dose Frequency
Omitted doses: 






Appendix 4 Template used to collect numbers and medicines of each category 
omitted
Data collection – Dose omissions                             
Station: Date:

























Appendix 5 Frequency (percentages in brackets) of omitted doses per day (n= 972) at the orthopaedic ward 
Day Patient absent 
from ward




Fasting patient Patient in 
Theatre
Patient unable to 
swallow




1 0    (0.00) 21    (3.91) 4    (0.74) 1    (0.19) 5    (0.93) 1    (0.19) 2    (0.37) 0    (0.00) 34    (6.33) 537
2 0    (0.00) 15    (3.18) 7    (1.49) 0    (0.00) 3    (0.64) 9    (1.91) 6    (1.27) 6    (1.27) 46    (9.77) 471
3 0    (0.00) 13    (2.64) 16    (3.25) 0    (0.00) 3    (0.61) 2    (0.41) 4    (0.81) 0    (0.00) 38    (7.71) 49
4 0    (0.00) 21    (4.43) 21    (4.43) 1    (0.21) 5    (1.05) 13   (2.74) 0    (0.00) 1    (0.21) 62    (13.08) 474
5 0    (0.00) 22    (4.65) 9    (1.90) 1    (0.21) 6    (1.27) 2    (0.42) 6    (1.27) 0    (0.00) 46    (9.73) 473
6 0    (0.00) 19    (4.45) 2    (0.47) 0    (0.00) 4    (0.94) 6    (1.41) 0    (0.00) 0    (0.00) 31    (7.62) 427
7 0    (0.00) 27    (5.71) 8    (1.69) 0    (0.00) 11   (2.33) 0    (0.00) 0    (0.00) 0    (0.00) 46    (9.73) 473
8 0    (0.00) 26    (7.51) 10    (2.89) 0    (0.00) 1    (0.29) 2    (0.58) 0    (0,00) 0    (0.00) 39    (11.27) 346
9 0    (0.00) 30    (5.03) 6    (1.01) 0    (0.00) 1    (0.17) 10   (1.68) 6    (1.01) 0    (0.00) 53    (8.88) 597
10 0    (0.00) 23    (4.81) 14    (2.93) 0    (0.00) 1    (0.21) 2    (0.42) 13   (2.72) 0    (0.00) 53    (11.09 478
11 0    (0.00) 32    (6.72) 13    (2.73) 0    (0.00) 4    (0.84) 11   (2.31) 3    (0.63) 0    (0.00) 63    (13.24) 476
12 0    (0.00) 24    (5.10) 7    (1.49) 0    (0.00) 3    (0.64) 20   (4.25) 0    (0.00) 0    (0.00) 54    (11.46) 471
13 0    (0.00) 15    (3.33) 10    (2.22) 0    (0.00) 5    (1.11) 0    (0.00) 0    (0.00) 3    (0.67) 33    (7.33) 450
14 0    (0.00) 20    (4.51) 9    (2.03) 0    (0.00) 6    (1.35) 4    (0.90) 0    (0.00) 2    (0.45) 41    (9.26) 443
15 0    (0.00) 28    (6.21) 14    (3.10) 0    (0.00) 3    (0.67) 0    (0.00) 5    (1.11) 0    (0.00) 50    (11.09) 451
16 0    (0.00) 23    (5.26) 5    (1.14) 0    (0.00) 0    (0.00) 1    (0.23) 14   (3.20) 0    (0.00) 43    (9.84) 437
17 1    (0.24) 22    (5.33) 11    (2.66) 0    (0.00) 4    (0.97) 0    (0.00) 1    (0.24) 0    (0.00) 39    (9.44) 413
18 3    (0.72) 24    (5.73) 10    (2.39) 1    (0.24) 5    (1.19) 1    (0.24) 0    (0.00) 0    (0.00) 44    (10.50) 419
19 0    (0.00) 33    (7.71) 9    (2.10) 0    (0.00) 0    (0.00) 10   (2.34) 1    (0.23) 0    (0.00) 53    (12.38) 428
20 0    (0.00) 42    (9.55) 1    (0.23) 0    (0.00) 3    (0.68) 15   (3.41) 1    (0.23) 0    (0.00) 62    (14.09) 440
21 0    (0.00) 37    (8.87) 2    (0.48) 0    (0.00) 3    (0.72) 0    (0.00) 0    (0.00) 0    (0.00) 42    (10.07) 417
Total 4   (0.07) 517   (5.38) 188   (1.96) 4   (0.04) 76   (0.79) 109  (1.13) 62   (0.64) 12   (0.12) 972 (10.11) 9614
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Appendix 6 Frequency (percentages in brackets) of omitted doses per day (n = 492) at the vascular ward
Day Patient absent 
from ward




Fasting patient Patient in 
Theatre
Patient unable to 
swallow




1 0    (0.00) 21    (5.57) 4    (1.06) 1    (0.27) 4    (1.06) 0    (0.00) 0    (0.00) 0    (0.00) 30    (7.96) 377
2 0    (0.00) 10    (2.82) 0    (0.00) 1    (0.28) 1    (0.28) 0    (0.00) 0    (0.00) 0    (0.00) 12    (3.39) 354
3 0    (0.00) 14    (3.93) 9    (2.53) 0    (0.00) 1    (0.28) 0    (0.00) 0    (0.00) 0    (0.00) 24    (6.74) 356
4 0    (0.00) 11    (3.08) 5    (1.40) 0    (0.00) 1    (0.28) 0    (0.00) 0    (0.00) 0    (0.00) 17    (4.76) 357
5 0    (0.00) 8    (2.35) 9    (2.64) 1    (0.29) 4    (1.17) 0    (0.00) 0    (0.00) 2    (0.59) 24    (7.04) 341
6 0    (0.00) 6    (1.65) 7   (1.89) 2    (0.54) 0    (0.00) 15    (4.04) 3    (0.81) 9    (2.43) 42    (11.32) 371
7 0    (0.00) 1    (0.30) 10    (2.96) 1    (0.30) 1    (0.30) 0    (0.00) 0    (0.00) 0    (0.00) 12    (3.55) 338
8 0    (0.00) 4    (1.12) 18    (5.04) 1    (0.28) 2    (0.56) 0    (0.00) 0    (0.00) 0    (0.00) 25    (7.00) 357
9 0    (0.00) 4    (1.10) 8    (2.21) 0    (0.00) 1    (0.26) 0    (0.00) 0    (0.00) 0    (0.00) 13    (3.59) 362
10 0    (0.00) 7    (1.95) 12    (3.34) 0    (0.00) 0    (0.00) 0    (0.00) 0    (0.00) 0    (0.00) 19    (5.29) 359
11 0    (0.00) 14    (3.83) 3    (0.82) 0    (0.00) 3    (0.82) 0    (0.00) 0    (0.00) 0    (0.00) 20    (5.46) 366
12 0    (0.00) 10    (2.77) 5    (1.39) 0    (0.00) 12    (3.32) 0    (0.00) 0    (0.00) 0    (0.00) 27    (7.48) 361
13 0    (0.00) 10    (2.63) 8    (2.11) 0    (0.00) 2    (0.53) 0    (0.00) 4    (1.05) 0    (0.00) 24    (6.32) 380
14 0    (0.00) 3    (0.71) 12    (2.83) 0    (0.00) 2    (0.47) 0    (0.00) 0    (0.00) 0    (0.00) 17    (4.01) 424
15 2    (0.48) 3    (0.71) 6    (1.43) 0    (0.00) 3    (0.71) 5    (1.19) 4    (0.95) 0    (0.00) 23    (5.48) 420
16 14    (3.47) 7    (1.74) 8    (1.99) 0    (0.00) 0    (0.00) 0    (0.00) 0    (0.00) 6    (1.49) 35    (8.68) 403
17 0    (0.00) 10    (2.34) 5    (1.17) 0    (0.00) 2    (0.47) 0    (0.00) 0    (0.00) 0    (0.00) 17    (3.97) 428
18 0    (0.00) 6    (1.26) 16    (3.35) 0    (0.00) 0    (0.00) 7    (1.47) 1    (0.21) 0    (0.00) 30    (6.29) 477
19 0    (0.00) 9    (2.07) 12    (2.76) 0    (0.00) 1    (0.23) 0    (0.00) 0    (0.00) 0    (0.00) 22    (5.06) 435
20 0    (0.00) 4    (0.83) 23    (4.75) 0    (0.00) 0    (0.00) 0    (0.00) 6    (1.24) 0    (0.00) 33    (6.82) 484
21 0    (0.00) 5    (1.01) 20    (4.04) 0    (0.00) 1    (0.20) 0    (0.00) 0    (0.00) 0    (0.00) 26    (5.25) 495
Total 16   (0.19) 167   (2.03) 200   (2.43) 7   (0.08) 41   (0.50) 27   (0.33) 18   (0.22) 17   (0.21) 492   (5.97) 8245
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